 | • レポートコード：MRC2305B097 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、245ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に1,797.99百万ドルであった世界のマウスモデル市場規模が、2022年には1,947.99百万ドルに達し、2027年までに年平均8.51％成長して2,936.56百万ドルになると予測しています。当調査資料では、マウスモデルの世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（条件付き/外科的改変マウス、遺伝子改変マウス、ハイブリッド/コンジェニックマウス、近交系マウス、異系交配マウス）、サービス別分析（育種、凍結保存、遺伝子検査、モデルインライセンス、検疫）、技術別分析（マイクロインジェクション、胚性幹細胞注入、核移植、バイオリスティックス、クリスパー/Cas9）、用途別分析（心血管研究、中枢神経系研究、糖尿病研究、免疫＆炎症研究、腫瘍研究）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目をまとめました。なお、当書に掲載されている企業情報には、Charles River Laboratories International, Inc.、Cyagen Biosciences、Envigo Ltd、GenOway S.A.、Harbour Antibodies Bv、Horizon Discovery Group plc、inGenious Targeting Laboratory、Janvier Labs、Ozgene Pty Ltd、PolyGeneなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のマウスモデル市場規模：種類別 - 条件付き/外科的改変マウスの市場規模 - 遺伝子改変マウスの市場規模 - ハイブリッド/コンジェニックマウスの市場規模 - 近交系マウスの市場規模 - 異系交配マウスの市場規模 ・世界のマウスモデル市場規模：サービス別 - 育種の市場規模 - 凍結保存の市場規模 - 遺伝子検査の市場規模 - モデルインライセンスの市場規模 - 検疫の市場規模 ・世界のマウスモデル市場規模：技術別 - マイクロインジェクションの市場規模 - 胚性幹細胞注入の市場規模 - 核移植の市場規模 - バイオリスティックスの市場規模 - クリスパー/Cas9の市場規模 ・世界のマウスモデル市場規模：用途別 - 心血管研究における市場規模 - 中枢神経系研究における市場規模 - 糖尿病研究における市場規模 - 免疫＆炎症研究における市場規模 - 腫瘍研究における市場規模 ・世界のマウスモデル市場規模：地域別 - 南北アメリカのマウスモデル市場規模 アメリカのマウスモデル市場規模 カナダのマウスモデル市場規模 ブラジルのマウスモデル市場規模 ... - アジア太平洋のマウスモデル市場規模 日本のマウスモデル市場規模 中国のマウスモデル市場規模 インドのマウスモデル市場規模 韓国のマウスモデル市場規模 台湾のマウスモデル市場規模 ... - ヨーロッパ/中東/アフリカのマウスモデル市場規模 イギリスのマウスモデル市場規模 ドイツのマウスモデル市場規模 フランスのマウスモデル市場規模 ロシアのマウスモデル市場規模 ... - その他地域のマウスモデル市場規模 ・競争状況 ・企業情報 |
The Global Mice Model Market size was estimated at USD 1,797.99 million in 2021 and expected to reach USD 1,947.99 million in 2022, and is projected to grow at a CAGR 8.51% to reach USD 2,936.56 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Mice Model to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Inbred Mice, Outbred Mice, and Spontaneous Mutant Mice.
Based on Service, the market was studied across Breeding, Cryopreservation, Genetic Testing, Model In-Licensing, Quarantine, and Rederivation.
Based on Technology, the market was studied across 10.3 Microinjection, 10.4 Embryonic Stem Cell Injection, 10.5 Nuclear Transfer, Biolistics, Crispr/Cas9, Genetically Modified Sperm-Mediated Gene Transfer, Liposome-Mediated DNA and Electroporation of DNA, Talens and Zfns, and Virus/Vector-Mediated Gene Transfer.
Based on Function, the market was studied across Bedding, Cages, and Feed.
Based on Application, the market was studied across Cardiovascular Studies, Central Nervous System Studies, Diabetes Studies, Immunology and Inflammation Studies, and Oncology Studies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Mice Model market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Mice Model Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Mice Model Market, including Charles River Laboratories International, Inc., Cyagen Biosciences, Envigo Ltd, GenOway S.A., Harbour Antibodies Bv, Horizon Discovery Group plc, inGenious Targeting Laboratory, Janvier Labs, Ozgene Pty Ltd, PolyGene, Taconic Biosciences, Inc., The Jackson Laboratory, TransGenic, Inc., and Vivo Bio Tech Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Mice Model Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Mice Model Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Mice Model Market?
4. What is the competitive strategic window for opportunities in the Global Mice Model Market?
5. What are the technology trends and regulatory frameworks in the Global Mice Model Market?
6. What is the market share of the leading vendors in the Global Mice Model Market?
7. What modes and strategic moves are considered suitable for entering the Global Mice Model Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Ongoing innovations in mice models for immune diseases, cancer, and rare diseases
5.1.1.2. Growing consumption of personalized medicine driving the demand for humanized mice models
5.1.1.3. Increasing support in the form of grants & investments and growing pharmaceutical R&D activities
5.1.1.4. Focus of associations on the development of embryonic stem cells as well as knockout and mutant mice
5.1.2. Restraints
5.1.2.1. Increased benefits from cryopreservation
5.1.2.2. Regulations and laws considering the ethical use of animals research
5.1.3. Opportunities
5.1.3.1. Rise of CRISPR as a powerful tool in the field of biomedical research
5.1.3.2. Increasing demand for humanized mice models
5.1.3.3. Increasing monoclonal antibody production
5.1.4. Challenges
5.1.4.1. Availability of alternative methods to animal testing
5.1.4.2. Improvements in zebrafish model development
5.1.4.3. Growing need for improved mice models
5.2. Cumulative Impact of COVID-19
6. Mice Model Market, by Type
6.1. Introduction
6.2. Conditioned/Surgically Modified Mice
6.3. Genetically Engineered Mice
6.4. Hybrid/Congenic Mice
6.5. Inbred Mice
6.6. Outbred Mice
6.7. Spontaneous Mutant Mice
7. Mice Model Market, by Service
7.1. Introduction
7.2. Breeding
7.3. Cryopreservation
7.4. Genetic Testing
7.5. Model In-Licensing
7.6. Quarantine
7.7. Rederivation
8. Mice Model Market, by Technology
8.1. Introduction
8.2. 10.3 Microinjection
8.3. 10.4 Embryonic Stem Cell Injection
8.4. 10.5 Nuclear Transfer
8.5. Biolistics
8.6. Crispr/Cas9
8.7. Genetically Modified Sperm-Mediated Gene Transfer
8.8. Liposome-Mediated DNA and Electroporation of DNA
8.9. Talens and Zfns
8.10. Virus/Vector-Mediated Gene Transfer
9. Mice Model Market, by Function
9.1. Introduction
9.2. Bedding
9.3. Cages
9.4. Feed
10. Mice Model Market, by Application
10.1. Introduction
10.2. Cardiovascular Studies
10.3. Central Nervous System Studies
10.4. Diabetes Studies
10.5. Immunology and Inflammation Studies
10.6. Oncology Studies
11. Americas Mice Model Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Mice Model Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Mice Model Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Charles River Laboratories International, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Cyagen Biosciences
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Envigo Ltd
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. GenOway S.A.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Harbour Antibodies Bv
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Horizon Discovery Group plc
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. inGenious Targeting Laboratory
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Janvier Labs
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Ozgene Pty Ltd
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. PolyGene
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Taconic Biosciences, Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. The Jackson Laboratory
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. TransGenic, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Vivo Bio Tech Ltd.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing